RBR-87x8h69招募中不适用
Effectiveness and safety of Dolutegravir among treatment-experienced children aged 6 to 12 years: a multicenter observational study in Brazil
Faculdade de Medicina, Universidade Federal de Minas Gerais/UFMG0 个研究点开始时间: 2022年11月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6Y 至 12Y（—）
入选标准
- •Children; both genders; from 6 to 12 years of age; weighing 20 kilos or more; infected by HIV (Human Immunodeficiency Virus); using a stable antiretroviral regimen; with a prescription for Dolutegravir.
排除标准
- •Any previous exposure to DTG (Dolutegravir) including participation in a clinical trial or a compassionate use/medical need program; history, presence of known allergy, or contraindications to DTG (Dolutegraivr) use; known previous genotypic resistance to Integrase Inhibitor.
研究者
相似试验
招募中
2 期
Evaluation of the effect of an antiretroviral drug in patients infected with HTLV-1.Human T-lymphotropic virus 1B04RBR-5x7ccxpFundação Bahiana de Infectologia - FBA
尚未招募
Unknown
Benefits and safety of major medicines in HIV patients.CTRI/2024/04/065522Institute of Medical Sciences, Banaras Hindu University
招募中
4 期
Safety and efficacy of Dolutegravir and EFV400 for pregnant and breastfeeding women: a randomized non-inferiority clinical trialHIV/AIDSPACTR201909810587438Hawassa University1,830
已完成
不适用
Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological SuppressionHIV InfectionNCT02491242Asociacion para el Estudio de las Enfermedades Infecciosas155
已完成
3 期
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)Infection, Human Immunodeficiency VirusHIV InfectionsNCT02831673ViiV Healthcare719